| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Oxford Science Enterprises plc | Former 10% Owner | 46 WOODSTOCK ROAD, OXFORD, UNITED KINGDOM | /s/ Jim Wilkinson | 01 Oct 2025 | 0001856079 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PEPG | Common Stock | Purchase | $640,000 | +200,000 | +4.2% | $3.20 | 4,955,388 | 30 Sep 2025 | Direct |
Oxford Science Enterprises plc is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
On September 30, 2025, Oxford Science Enterprises plc purchased 200,000 shares of Common Stock at a price of $3.20 per share from the underwriters in the Issuer's public offering (the "2025 Public Offering"), bringing the total number of shares of Common Stock beneficially owned by Oxford Science Enterprises plc to 4,955,388. On September 24, 2025, the Issuer disclosed in its prospectus supplement, dated September 24, 2025, filed with the SEC on September 25, 2025, that it had 68,737,224 shares of Common Stock outstanding as of September 26, 2025. Accordingly, Oxford Science Enterprises plc is no longer deemed to beneficially own more than 10% of the Issuer's Common Stock. Oxford Science Enterprises plc is no longer subject to Section 16 of the Exchange Act with respect to the Issuer's Common Stock, and therefore will no longer report any such transactions on Form 4 or Form 5.